MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	6.05B -4.9%
Revenue (ttm)	879.66M +3.8%
Net Income	205.32M -27.4%
EPS	0.36 -27.1%
Shares Out	575.97M
PE Ratio	29.49
Forward PE	17.16
Dividend	0.22 (2.10%)
Ex-Dividend Date	Jul 2, 2026

Volume	1,214,030
Average Volume	3,345,634
Open	10.38
Previous Close	10.37
Day's Range	10.23 - 10.68
52-Week Range	9.02 - 19.06
Beta	-0.10
RSI	41.00
Earnings Date	Mar 25, 2026

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 522
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2025, MicroPort NeuroScientific's revenue was 790.48 million, an increase of 3.77% compared to the previous year's 761.76 million. Earnings were 184.51 million, a decrease of -27.41%.

Financial numbers in CNY